| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2020 | EpCAM signaling promotes tumor progression and protein stability of PD-L1 through EGFR pathway | Chen, H. N.; Liang, K. H.; Lai, J. K.; Lan, C. H.; Liao, M. Y.; Hung, S. H.; Chuang, Y. T.; Chen, K. C.; Tsuei, W. W. F.; Wu, H. C. | Cancer Research 80(22), 5035-5050 | | | |
| 2018 | Hepatocellular carcinoma-targeted nanoparticles for cancer therapy | Wu, C. H.; Lan, C. H.; Wu, K. L.; Wu, Y. M.; Jane, W. N.; Hsiao, M.; Wu, H. C. | International Journal of Oncology 52(2), 389-401 | | | |
| 2017 | Panobinostat sensitizes KRAS-mutant non-small-cell lung cancer to gefitinib by targeting TAZ. | Lee, W. Y.; Chen, P. C.; Wu, W. S.; Wu, H. C. ; Lan, C. H.; Huang, Y. H.; Cheng, C. H.; Chen, K. C.; Lin, C. W. | International Journal of Cancer 141(9), 1921-1931 | | | |
